Orthopediatrics (KIDS) revenue breakdown
By product, Trauma and deformity is the largest at 70% of fiscal 2025 revenue; Scoliosis grew fastest, 24% a year over 9 years.
By region, U.S. is the largest at 79% of fiscal 2025 revenue, growing 23% a year over 9 years.
Revenue by product
Fiscal years, as Orthopediatrics reports them in its 10-K filings; fiscal 2025 total $236M.
| Products | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Share |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Trauma and deformity | $27M | $33M | $40M | $49M | $48M | $66M | $85M | $107M | $145M | $166M | 70% |
| Scoliosis | $9M | $12M | $17M | $21M | $21M | $28M | $33M | $38M | $55M | $66M | 28% |
| Sports medicine/other | $1M | $1M | $1M | $2M | $3M | $4M | $4M | $4M | $4M | $4M | 2% |
Revenue by region
Fiscal years, as Orthopediatrics reports them in its 10-K filings; fiscal 2025 total $236M.
| Regions | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Share |
|---|---|---|---|---|---|---|---|---|---|---|---|
| U.S. | $29M | $35M | $43M | $55M | $63M | $78M | $92M | $111M | $161M | $186M | 79% |
| International | $8M | $11M | $14M | $17M | $8M | $20M | $30M | $38M | $44M | $50M | 21% |
Every line, every quarterThe deep dive has fifteen-plus years of statements, quarterly results, charts and valuation models for KIDS.
Open KIDS in InvestinglyQuestions
Where does Orthopediatrics make its money?
In fiscal 2025, by product: Trauma and deformity $166M, Scoliosis $66M, Sports medicine/other $4M.
From Orthopediatrics's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.